Ronda Farah, MD

home / authors / ronda-farah-md

Articles

What’s New in Hair Loss Therapies and Exosomes?

What’s New in Hair Loss Therapies and Exosomes?

Kaitlyn Bader, Senior Editor ;Ronda Farah, MD
March 12th 2024

Ronda Farah, MD, FAAD, reviews top hair loss pearls from her 5 sessions at AAD 2024.

Considerations to Best Serve Transgender Patients Seeking Aesthetic Care

Considerations to Best Serve Transgender Patients Seeking Aesthetic Care

Sophia Fruechte;Ronda Farah, MD;Zachary Wendland, MD ;Nathalie Ly;James Pathoulas, MD;Klint Peebles, MD
June 22nd 2023

Ronda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.

Latest Updated Articles

2 KOLs are featured in this series.
Published: September 19th 2024 | Updated: September 26th 2024
Final Thoughts: The Importance of Comparative Studies in AD
Optimizing Laser Therapy for Vascular Anomalies: Why Early Multidisciplinary Care Matters
Published: March 11th 2025 | Updated: April 1st 2025
Optimizing Laser Therapy for Vascular Anomalies: Why Early Multidisciplinary Care Matters
Apoptosis-Based Skin Cancer Treatment Shows Promise
Published: March 15th 2025 | Updated: April 1st 2025
Apoptosis-Based Skin Cancer Treatment Shows Promise
Tattoo Ink Risks, MultiFrax Laser, and the Impact of GLP-1 Medications on Skin Health
Published: March 7th 2025 | Updated: April 1st 2025
Tattoo Ink Risks, MultiFrax Laser, and the Impact of GLP-1 Medications on Skin Health
Insights From the ADORING 3 Study and Tapinarof’s Treatment-Free Periods in AD
Published: March 8th 2025 | Updated: April 1st 2025
Insights From the ADORING 3 Study and Tapinarof’s Treatment-Free Periods in AD
Late-Breaking Data: Phase 3 Updates on Ruxolitinib Cream for Prurigo Nodularis
Published: March 8th 2025 | Updated: April 1st 2025
Late-Breaking Data: Phase 3 Updates on Ruxolitinib Cream for Prurigo Nodularis
© 2025 MJH Life Sciences

All rights reserved.